Have a personal or library account? Click to login
Overview of the serologic and molecular basis of D variants with a focus on D variants in the Indian population Cover

Overview of the serologic and molecular basis of D variants with a focus on D variants in the Indian population

Paid access
|Apr 2023

References

  1. International Society of Blood Transfusion. Table of blood group systems. Available from https://www.isbtweb.org/resource/tableofbloodgroupsystems.html. Accessed 1 March 2023.
  2. Dean L. Blood groups and red cell antigens. Bethesda, MD: National Center for Biotechnology Information, 2005.
  3. Kumar H, Mishra DK, Sarkar RS, Jaiprakash M. Difficulties in immunohaematology: the weak D antigen. Med J Armed Forces India 2005;61:348–50.
  4. Kulkarni SS, Gupte SC, Vasantha K, Mohanty D, Ghosh K. Varied distribution of RhD epitopes in the Indian population. Natl Med J India 2007;20:169–71.
  5. Thakral B, Saluja K, Sharma RR, Marwaha N. Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donors. Transfus Apher Sci 2010;43:17–22.
  6. Stratton F. A new Rh allelomorph. Nature 1946;158:25.
  7. Argall CI, Ball JM, Trentelman E. Presence of anti-D antibody in the serum of a Du patient. J Lab Clin Med 1953;41:895–8.
  8. Simmons RT, Krieger VI. Anti-Rho (D) antibodies produced by isoimmunization in an Rh positive mother of the unusual genotype ℛ1ry (CDue/CdE). Med J Aust 1960;1:1021–2.
  9. Hill Z, Vacl J, Kalasová E, Calábková M, Pintera J. Haemolytic disease of new-born due to anti-D antibodies in a Du-positive mother. Vox Sang 1974;27:92–4.
  10. Agre PC, Davies DM, Issitt PD, et al. A proposal to standardize terminology for weak D antigen. Transfusion 1992;32:86–7.
  11. Tippett P, Sanger R. Observations on subdivisions of the Rh antigen D. Vox Sang 1962;7:9–13.
  12. Wiener AS, Unger LJ. Further observations on the blood factors RhA, RhB, RhC and RhD. Transfusion 1962;2:230–3.
  13. Daniels G. Variants of RhD: current testing and clinical consequences. Br J Haematol 2013;161:461–70.
  14. Kwon DH, Sandler SG, Flegel WA. DEL phenotype. Immunohematology 2017;33:125.
  15. McGann H, Wenk RE. Alloimmunization to the D antigen by a patient with weak D type 21. Immunohematology 2010;26:27–9.
  16. Yasuda H, Ohto H, Sakuma S, Ishikawa Y. Secondary anti-D immunization by Del red blood cells. Transfusion 2005;45:1581–4.
  17. Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000;95:2699–708.
  18. Sandler SG, Flegel WA, Westhoff CM, et al. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. Transfusion 2015;55:680–9.
  19. Fung MK, Grossman BJ, Hillyer CD, et al., Eds. Technical manual. 18th ed. Bethesda, MD: AABB, 2014.
  20. Scott M. Rh serology: coordinator’s report. Transfus Clin Biol 1996;3:333.
  21. Salmon C, Cartron JP, Rouger P. The human blood groups. Masson; New York: 1984.
  22. Issitt PD, Telen MJ. Introduction of the term “partial D.” Transfusion 1996;36:761–2.
  23. Unger LJ, Wiener AS, Katz L. Studies on blood factors RhA, RhB, and RhC. J Exp Med 1959;110:495–510.
  24. Tippett P. Rh blood group system: the D antigen and high- and low-frequency Rh antigens. In: Vengelen-Tyler V, Pierce S, Eds. Blood group systems: Rh. Arlington: AABB 1987:25–53.
  25. Tippett P, Lomas-Francis C, Wallace M. The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sang 1996;70:123–31.
  26. Okubo Y, Yamaguchi H, Tomita T, Nagao N. A D variant, Del? Transfusion 1984;24:542.
  27. Körmöczi GF, Gassner C, Shao CP, Uchikawa M, Legler TJ. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 2005;45:1561–7.
  28. Kim KH, Kim KE, Woo KS, Han JY, Kim JM, Park KU. Primary anti-D immunization by DEL red blood cells. Korean J Lab Med 2009;29:361–5.
  29. Yang HS, Lee MY, Park TS, et al. Primary Anti-D alloimmunization induced by “Asian Type” RHD (c.1227G>A) DEL red cell transfusion. Ann Lab Med 2015;35:554–6.
  30. Lukacevic Krstic J, Dajak S, Bingulac-Popovic J, Dogic V, Mratinovic-Mikulandra J. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population. J Clin Lab Anal 2018;32:e22285.
  31. Jeong D, Oh S, Song EY, Hong YJ, Park KU. Molecular characteristics of the serological weak D phenotype in Koreans. Diagnostics 2021;11:920.
  32. Vege S, Westhoff CM. Rh and RhAG blood group systems. In: Shaz B, Hillyer C, Eds. Transfusion medicine and hemostasis. Philadelphia: Elsevier, 2019:149–55.
  33. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000;95:3662–8.
  34. Daniels G. Human blood groups. Hoboken, NJ: John Wiley & Sons, 2008.
  35. Sandler SG, Chen LN, Flegel WA. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype. Br J Haematol 2017;179:10–9.
  36. Wagner FF, Eicher NI, Jørgensen JR, Lonicer CB, Flegel WA. DNB: a partial D with anti-D frequent in Central Europe. Blood 2002;100:2253–6.
  37. Wagner FF, Gassner C, Müller TH, et al. Three molecular structures cause Rhesus D category VI phenotypes with distinct immunohematologic features. Blood 1998;91: 2157–68.
  38. Wagner FF. RHD PCR of D-negative blood donors. Transfus Med Hemother 2013;40:172–81.
  39. Hasekura H, Ota M, Ito S, et al. Flow cytometric studies of the D antigen of various Rh phenotypes with particular reference to Du and Del. Transfusion 1990;30:236–8.
  40. Wagner FF, Flegel WA. The rhesus site. Transfus Med Hemother 2014;4:1357–63. (The human RhesusBase, version 2.5.2, updated 2020-03-18. Available from http://www.rhesusbase.info/. Accessed 1 March 2023.
  41. Garratty G. Do we need to be more concerned about weak D antigens? Transfusion 2005;45:1547–51.
  42. Contreras M, Knight RC. Controversies in transfusion medicine: testing for Du. Transfusion 1991;31:270–2.
  43. Kulkarni S, Colah R, Gorakshakar A, et al. Frequency of partial D in western India. Transfus Med 2008;18:91–6.
  44. Kulkarni S, Kasiviswanathan V, Ghosh K. A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population. Blood Transfus 2013;11:37.
  45. Fichou Y, Parchure D, Gogri H, et al. Molecular basis of weak D expression in the Indian population and report of a novel, predominant variant RHD allele. Transfusion 2018;58 1540–9.
  46. Mishra G, Sachan D, Krishna D, Parchure D, Madkaikar M, Kulkarni S. Characterising Indian RhD variants by serological and molecular methods. Transfus Med 2020;30:324–6.
  47. Polavarapu I, Mishra G, Shastry S, Kulkarni S. Molecular characterization of RhD variant phenotypes among blood donors: a study from the coastal region of India. Transfus Apher Sci 2021:103142.
  48. Khetan D, Verma A, Chaudhary RK, Shukla JS. Molecular characterisation of RhD variants in North Indian blood donor population. Transfus Med 2020;30:295–303.
  49. Kulkarni S, Parchure DS, Gopalkrishnan V, Madkaikar M. Screening for DEL phenotype in RhD negative Indians. J Clin Lab Anal 2018;32:e22288.
  50. Thongbut J, Raud L, Férec C, Promwong C, Nuchnoi P, Fichou Y. Comprehensive molecular analysis of serologically D-negative and weak/partial D phenotype in Thai blood donors. Transfus Med Hemotherapy 2020;47:54-60.
  51. Thongbut J, Laengsri V, Raud L, et al. Nation-wide investigation of RHD variants in Thai blood donors: impact for molecular diagnostics. Transfusion 2021;61:931-8.
  52. ISBT 2022: Abstract Book. Vox Sang 2022;117:6-271. https://doi.org/10.1111/vox.13285
  53. Khaja Pasha RP, Shokri F. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN). Iran J Immunol 2008;5:189–200.
  54. Klein HK, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 11th ed. Oxford, UK: Blackwell Publishing, 2005.
  55. Westhoff CM. The structure and function of the Rh antigen complex. Semin Hematol 2007;44:42–50.
  56. Flegel WA. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol 2006;13:476–83.
  57. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385–93.
  58. Le Maréchal C, Guerry C, Benech C, et al. Identification of 12 novel RHD alleles in western France by denaturing high-performance liquid chromatography analysis. Transfusion 2007;47:858–63.
  59. Lacey PA, Caskey CR, Werner DJ, Moulds JJ. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 1983;23:91–4.
  60. Luo X, Keller MA, James I, et al. Strategies to identify candidates for D variant genotyping. Blood Transfus 2018;16:293.
  61. Mak KH, Yan KF, Cheng SS, Yuen MY. Rh phenotypes of Chinese blood donors in Hong Kong, with special reference to weak D antigens. Transfusion 1993;33:348–51.
  62. Wagner T, Körmöczi GF, Buchta C, et al. Anti-D immunization by DEL red blood cells. Transfusion 2005;45:520–6.
  63. Wang M, Wang BL, Xu W, et al. Anti-D alloimmunisation in pregnant women with DEL phenotype in China. Transfus Med 2015;25:163–9.
  64. Shao C, Wang B, Ye S, et al. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness. J Zhejiang Univ Sci B 2012;13:913–8.
  65. Sandler SG, Roseff S, Dormen RE, et al. Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the comprehensive transfusion medicine survey of the College of American Pathologists. Arch Pathol Lab Med 2014;138:620–5.
  66. Engelfriet CP, Reesink HW. Testing for weak D. Vox Sang 2006;90:140–53.
  67. de Vries R, Haas F. English translation of the Dutch Blood Transfusion guideline 2011. Clin Chem 2012;58:1266.
  68. Milkins C, Berryman J, Cantwell C, et al.; British Committee for Standards in Haematology. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. Transfus Med 2013;23:3–35.
  69. Denomme GA, Flegel WA. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008;48:2461–75.
  70. von Zabern I, Wagner FF, Moulds JM, Moulds JJ, Flegel WA. D category IV: a group of clinically relevant and phylogenetically diverse partial D. Transfusion 2013;53:2960–73.
  71. Crottet SL, Henny C, Meyer S, et al. Implementation of a mandatory donor RHD screening in Switzerland. Transfus Apher Sci 2014;50:169–74.
DOI: https://doi.org/10.21307/immunohematology-2023-005 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 19 - 31
Published on: Apr 5, 2023
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 D.S. Parchure, G.V. Mishra, S.S. Kulkarni, published by American National Red Cross
This work is licensed under the Creative Commons License.